Relay Therapeutics Inc. Gains 23.75%
Thu, Sep 08, 2022 at 07:25 PM

Relay Therapeutics Inc. (RLAY:NASDAQ) shot up at $31.37, a gain of 23.7%. On Thu, Sep 08, 2022, RLAY:NASDAQ hit a New 2-Week High of $31.37. The stock got featured on our News Catalysts scanner on Thu, Sep 08, 2022 at 02:42 PM in the 'BIOTECH' category. From Thu, Aug 25, 2022, the stock recorded 55.56% Up Days and 40.00% Green Days
About Relay Therapeutics Inc. (RLAY:NASDAQ)
Relay Therapeutics Inc is a clinical-stage, precision medicines company transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted...
Top 10 Gainers:
- ShiftPixy, Inc. (PIXY:NASDAQ), 176.54%
- Amylyx Pharmaceuticals Inc. (AMLX:NASDAQ), 51.01%
- Rubius Therapeutics, Inc. (RUBY:NASDAQ), 48.58%
- Benitec Biopharma Inc. (BNTC:NASDAQ), 33.02%
- Marker Therapeutics, Inc. (MRKR:NASDAQ), 31.5%
- Palatin Technologies, Inc. (PTN:NYSEMKT), 26.2%
- LifeStance Health Group Inc. (LFST:NASDAQ), 25.76%
- Asana Inc. Class A (ASAN:NYSE), 24.79%
- Relay Therapeutics Inc. (RLAY:NASDAQ), 23.75%
- Revance Therapeutics, Inc. (RVNC:NASDAQ), 21.58%